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Abstract
The aim of this study was to determine the relationship between
urinary albumin excretion (UAE), cardiac structural changes upon
echocardiography and 24-h ambulatory blood pressure (ABPM) lev-
els. Twenty mild hypertensive patients (mean age 56.8 ± 9.6 years)
were evaluated. After 2 weeks of a washout period of all antihyperten-
sive drugs, all patients underwent an echocardiographic evaluation, a
24-h ABPM and an overnight urine collection. Systolic and diastolic
blood pressure during 24-h ABPM was 145 ± 14/91 ± 10 mmHg
(daytime) and 130 ± 14/76 ± 8 mmHg (nighttime), respectively. Seven
(35%) patients presented UAE ≥15 µg/min, and for the whole group,
the geometric mean value for UAE was 10.2 x/÷ 3.86 µg/min. Cardiac
measurements showed mean values of interventricular septum thick-
ness (IVS) of 11 ± 2.3 mm, left ventricular posterior wall thickness
(PWT) of 10 ± 2.0 mm, left ventricular mass (LVM) of 165 ± 52 g, and
left ventricular mass index (LVMI) of 99 ± 31 g/m2. A forward
stepwise regression model indicated that blood pressure levels did not
influence UAE. Significant correlations were observed between UAE
and cardiac structural parameters such as IVS (r = 0.71, P<0.001),
PWT (r = 0.64, P<0.005), LVM (r = 0.65, P<0.005) and LVMI (r =
0.57, P<0.01). Compared with normoalbuminuric patients, those who
had microalbuminuria presented higher values of all cardiac param-
eters measured. The predictive positive and negative values of UAE
≥15 µg/min for the presence of geometric cardiac abnormalities were
75 and 91.6%. These data indicate that microalbuminuria in essential
hypertension represents an early marker of cardiac structural damage.
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Introduction
Several studies have demonstrated that
24-h ambulatory blood pressure monitoring
(ABPM) is more closely related to target
organ damage than casual measurements
(1,2). Cardiac structures assessed by echo-
cardiography such as left ventricular mass
index (LVMI), left ventricular mass (LVM)
or the relative thickness of left ventricular
posterior wall (PWT) and interventricular
septum (IVS) have shown good correlations
with 24-h systolic blood pressure (3). Not
only cardiac structural changes but also other
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abnormalities in target organs of hyperten-
sion such as retinopathy (4) and urinary
albumin excretion (UAE) have shown a cor-
relation with ABPM (5).
Increased UAE has been reported to be a
strong predictor of cardiovascular events in
hypertensive patients. The importance of this
finding is not completely clear but it seems
that there is an association between UAE
and the other cardiovascular risk factors such
as obesity, insulin resistance, impaired lipid
profile and blood pressure (6-8).
The prevalence of microalbuminuria in
untreated hypertensive patients ranges from
20 to 40% according to the method used (9-
11). In some studies patients treated with
diuretics or beta-blockers showed a preva-
lence of 25%, while others have described a
prevalence of proteinuria in a range of 4 to
16% (12,13). The degree of microalbuminu-
ria was positively correlated with office blood
pressure although better correlations have
been observed using 24-h ambulatory moni-
toring. Also, a negative correlation has been
detected between UAE and the nocturnal
blood pressure fall (14-16). Some clinical
studies have shown not only a positive corre-
lation between blood pressure levels and
microalbuminuria, but also a positive corre-
lation between microalbuminuria and other
target organs of hypertensive disease such as
LVM and retinopathy (17,18).
Increased UAE by essential hypertensive
patients has been interpreted to be a marker
of early intrarenal vascular endothelial dys-
function (19). It may be also a risk factor for
renal function deterioration (20). The aim of
the present study was to determine the rela-
tionship between microalbuminuria, cardiac
structural changes and blood pressure levels
determined by 24-h ambulatory monitoring,
in mild hypertensive patients.
Patients and Methods
Patients of both sexes considered to be
mild hypertensives (defined as patients with
blood pressure levels below 159 mmHg for
systolic pressure and 99 mmHg for diastolic
pressure after 2 weeks of withdrawal of their
antihypertensive medication and no evidence
of target organ damage) were eligible for
inclusion. They were seen regularly at
3-month intervals at the Hypertension and
Diabetes Outpatient Clinic, Hospital do Rim
e Hipertensão. Patients with abnormal fast-
ing glucose (≥126 mg/dl) and serum creati-
nine levels (>1.2 mg/dl), as well as those
with abnormalities upon echocardiogram
evaluation or heart disease were not included.
A total of 20 patients (6 men/14 women aged
42-70 years) were evaluated. The time since
the diagnosis of hypertension ranged from 1
to 47 years (mean of 13.7 ± 10.2 years).
None of the participants had any clinical
hypertensive complications. The local Eth-
ics Committee (UNIFESP) approved this
protocol which conformed to the guidelines
of the Declaration of Helsinki and informed
consent was obtained from the subjects.
Blood pressure determinations
Office blood pressure. Blood pressure
levels were determined after at least 5 min of
rest in the sitting position using a mercury
sphygmomanometer. The same physician
performed all measurements and a mean of
three determinations was used. Systolic and
diastolic blood pressure corresponded to
phases I and V of the Korotkoff sound, re-
spectively.
Blood pressure monitoring. ABPM was
performed using a noninvasive automatic
monitor (SpaceLabs, model 90207). We con-
sidered the period during which subjects
carried out their normal activities as daytime
and nighttime as the period of sleeping. Blood
pressure was measured every 15 min during
the daytime and every 20 min during the
nighttime. The data for subjects with less
than 80% of valid measurements were ex-
cluded from analysis. The measurements of
the mean systolic and diastolic blood pres-
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sure obtained from this evaluation were used
in the subsequent analysis. All participants
were asked to perform their normal daily
activities.
Echocardiography. Cardiac structures
were evaluated with an M-mode and two-
dimensional echocardiographic Esaote
Biomedica apparatus (Florence, Italy), mo-
del SIM 5000, equipped with a 2.5-MHz
mechanical transducer. Patients lay in left
decubitus with a slight rotation of the chest.
The echocardiographic parameters evaluated
were PWT, IVS, both measured at diastole,
and LVM calculated according to the Ameri-
can Society of Echocardiography (21).
LVMI was obtained by dividing LMV by
body surface area and was considered nor-
mal when the values were below 110 g/m2
for women and 134 g/m2 for men.
Relative IVS (RIVS) and relative PWT
(RPWT) were calculated from the following
expressions:
RIVS = 2 x IVS (mm)/LVEDD (mm)
RPWT = 2 x PWT (mm)/LVEDD (mm)
where LVEDD = left ventricle end-diastolic
diameter.
Laboratory parameters. All patients had
an overnight (12 h) urine sample collected
for UAE measurement, using an immunotur-
bidimetric method with a specific antibody
automatized by CobasMira Plus, Roche
(Basel, Switzerland).
Statistical analysis
Data were analyzed with the SigmaStat
for Windows software, version 1.0 (Jandel
Corporation, Chicago, IL, USA). Data are
reported as mean ± SD or median and its
confidence intervals. Forward stepwise re-
gression analysis was used to identify the
variables that could be predictors or determi-
nants of microalbuminuria and cardiac struc-
tural changes. The correlation between car-
diac and renal variables was determined by
Spearman correlation. For further analysis,
microalbuminuria values were log trans-
formed to correct the skewing in distribu-
tion. The association between microalbumi-
nuria and increased values of cardiac param-
eters was tested by Fisher’s exact test. Dif-
ferences were considered significant at
P<0.05.
Results
Table 1 shows the clinical characteristics
of the subjects. Blood pressure levels ob-
tained with 24-h ABPM showed a mean for
systolic and diastolic pressure of 145 ± 14/
91 ± 10 mmHg (vigil) and 130 ± 14/76 ± 8
mmHg (sleep), respectively, and the median
blood pressure fall during sleep was 10.5%
(5.2-17.1).
Cardiac evaluation showed that 8 pa-
tients (40%), 3 men and 5 women, had both
IVS and PWT above the normal range and 4
(20.0%), one man and 3 women, had left
ventricular hypertrophy when adjusted for
sex. The mean values of these parameters for
the remaining subjects were within the nor-
mal range: IVS - 11 ± 2.3 mm, PWT - 10 ±
2.0 mm, LVM - 165 ± 52 g and LVMI - 99 ±
31 g/m2.
Urinary albumin excretion greater than
15 µg/min (defined as microalbuminuria)
was found in 7 (35%) patients and the geo-
Table 1. Clinical characteristics of the normoalbuminuric (NA) and the microalbuminuric
(MA) patients.
Characteristics All subjects NA MA
(N = 20) (N = 13) (N = 7)
Age (years) 56.8 ± 9.6 55.0 ± 10.3 60.0 ± 7.0
Duration of hypertension (years) 13.7 ± 10.2 14.2 ± 11.8 12.6 ± 6.8
Body mass index (kg/m2) 27.7 ± 4.1 27.2 ± 11.8 28.8 ± 2.6
Office systolic blood pressure (mmHg) 147.0 ± 11.7 146.3 ± 17.2 147.9 ± 16.3
Office diastolic blood pressure (mmHg) 87.0 ± 7.0 86.4 ± 6.7 87.1 ± 7.6
Serum glucose (mg/dl) 86.8 ± 14.2 86.3 ± 12.7 86.7 ± 16.8
UAE (µg/min) 10.2 x/÷ 3.86 4.53 x/÷ 1.68 44.3 x/÷ 2.61
Data are reported as means ± SD. Data for urinary albumin excretion (UAE) are
reported as geometric mean and SD.
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metric mean value was 10.2 x/÷ 3.86 µg/
min, ranging from 1.5 to 173 µg/min.
When a stepwise regression model was
applied, no ABPM values (mean 24-h, vigil
and night), age, BMI or duration of hyper-
tension showed any influence on UAE. When
the same model was applied to cardiac struc-
tures only LVMI was influenced by the time
of diagnosis of hypertension and sleeptime
diastolic blood pressure (r2 = 0.60, P<0.05).
The duration of the hypertensive process
could explain 44% of the increases observed
in LVMI and the nighttime diastolic blood
pressure levels could explain 16%.
The Spearman test indicated a positive
and significant correlation between UAE and
cardiac measurements such as absolute IVS
(r = 0.71, P<0.001) and PWT (r = 0.64,
P<0.005) (Figure 1), as well as between
UAE and relative IVS (r = 0.52, P<0.02) and
PWT (r = 0.49, P<0.03) (Figure 2). Urinary
albumin excretion was also correlated with
LVM (r = 0.65, P<0.005) and LVMI (r =
0.57, P<0.01).
A comparison between normoalbumin-
uric (N = 13) and microalbuminuric (N = 7)
patients showed no differences regarding
age, BMI, duration of hypertension or blood
pressure values determined during ABPM
(Table 2). In contrast, the cardiac parameters
indicated statistically significant differences
between groups (Table 3).
Microalbuminuria (UAE >15 µg/min)
showed a positive predictive value of 75%
and a negative predictive value of 91.6%
(Table 4) for geometric cardiac abnormalities.
Discussion
Microalbuminuria has been considered
to be a marker of cardiovascular risk in
diabetic (22,23) and non-diabetic subjects
(6). The importance of increased UAE levels
in essential hypertension is unclear. How-
ever, increased UAE has been related not
only to blood pressure levels (24) and left
ventricular hypertrophy (17) but also to sev-
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Figure 1. Correlations of microalbuminuria with interventricular septum thickness (IVS) and
with left ventricular posterior wall thickness (PWT) for 20 patients.
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Figure 2. Correlations of microalbuminuria with relative left ventricular wall thickness
(RPWT) and with relative interventricular septum thickness (RIVS) for 20 patients.
Table 2. Blood pressure obtained by 24-h ambulatory blood pressure monitoring of the
NA and MA patients.
Blood pressure (mmHg) All patients NA MA
(N = 20) (N = 13) (N = 7)
Vigil
SBP 145 ± 14 143 ± 11 150 ± 19.7
DBP 91 ± 10 88.9 ± 9.5 95.2 ± 10.2
Sleep
SBP 130 ± 14 130 ± 13.8 130 ± 16.2
DBP 76 ± 8.0 74.8 ± 8.6 77.2 ± 7.3
Nocturnal fall (%) 10.6 ± 6.5 9.4 ± 6.9 13.2 ± 5.0
Data are reported as means ± SD. NA, normoalbuminuric patients; MA, microalbu-
minuric patients; SBP, systolic blood pressure; DBP, diastolic blood pressure.
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eral other risk factors such as hyperinsuline-
mia, dislipidemia and obesity, which com-
prise a cluster of metabolic abnormalities
(8,15,25,26).
In the present study, UAE was not ex-
plained by any of the variables included in a
regression model, such as age, duration of
hypertension, or BMI. These findings are con-
sistent with the data reported by Palatini et al.
(26). In contrast to some reports (20,27), our
results did not show any correlation between
UAE and blood pressure. This suggests that
UAE is not directly dependent on blood pres-
sure levels but depends on renal vascular dam-
age secondary to the hypertensive process.
The association between UAE levels and
LVMI demonstrated in our patients has also
been reported in untreated hypertensives and
in patients with white coat hypertension
(28,29). In our study, correlations were also
detected between absolute or relative IVS
and PWT values and UAE. These findings
indicate that UAE is associated with concen-
tric cardiac remodeling, the structural change
that precedes the development of left ven-
tricular hypertrophy. This finding supports
data reported by Pontremoli et al. (30) who
also reported a higher prevalence of unfa-
vorable left ventricular geometric patterns in
microalbuminuric patients. The comparison
between normoalbuminuric and microalbu-
minuric subjects confirms our hypothesis
that microalbuminuria is a marker of early
cardiac changes, as previously suggested in
the literature (31). As shown by Bulatov et
al. (32), there is a continuous relationship
between albumin excretion rate, LVM as-
sessed by echocardiography, and ambula-
tory blood pressure in newly diagnosed pa-
tients with essential hypertension. This sug-
gests that the early effects of blood pressure
on target organs such as kidneys and heart
occur in parallel (32). The presence of mi-
croalbuminuria has been understood to be a
renal manifestation of generalized increased
endothelial dysfunction.
Our data agree with observations sug-
gesting that determination of UAE is useful
for the identification of a subset of patients
who could be more prone to developing left
ventricular hypertrophy, contributing to the
stratification of cardiovascular risk in hyper-
tensive patients (25,27,33,34).
The presence of increased UAE levels in
mild hypertension and its association with
cardiac structure abnormalities may be con-
sidered to be not only evidence of early renal
vascular damage, but also as a marker of
geometric cardiac changes.
Taking into account the positive predic-
tive value found in this study, the presence of
microalbuminuria in hypertensive subjects
seems to be a very important test to be con-
sidered in the evaluation of cardiovascular
risk in this population.
Table 3. Cardiac structure measurements of normoalbuminuric (NA) and microalbu-
minuric (MA) patients.
Cardiac structures NA MA P
(N = 13) (N = 7)
IVS (mm) 9.6 ± 2.0 12.4 ± 1.8 0.007
PWT (mm) 9.3 ± 1.5 11.7 ± 1.3 0.0025
LVM (g) 144 ± 47 203 ± 45 0.016
LVMI (g/m2) 80 (74.5-93) 114 (107-128.5) 0.009
RIVS 0.41(0.36-0.48) 0.51 (0.50-0.57) NS
RPWT 0.41 (0.37-0.52) 0.55 (0.50-0.60) NS
Data are reported as means ± SD or medians (95% confidence intervals). IVS,
interventricular septum thickness; PWT, left ventricular posterior wall thickness; LVM,
left ventricular mass; LVMI, left ventricular mass index; RIVS, relative interventricular
septum thickness; RPWT, relative posterior wall thickness; NS, not significant. The
two patient groups were compared by the Student t-test or Wilcoxon test for median
and CI.
Table 4. Predictive value of urinary albumin excre-
tion (UAE) regarding cardiac structural changes
(CSC).
UAE UAE
>15 µg/min ≤15 µg/min
(N = 7) (N = 13)
Presence of CSC 6 2
Absence of CSC 1 11
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